Objective: Notwithstanding the increasing recognition of occult hip fracture the diagnosis is not suspected in some patients who present later with displaced hip fracture. We wished to investigate if the “missed occult fracture” group had any distinct demographic or clinical details and the eventual outcome of delayed diagnosis and treatment.

Methods: Over a three year period we followed all patients admitted with fracture neck of femur to identify patients where the diagnosis was initially missed and compared them with patients admitted over the same period with a correct suspicion of occult hip fracture.

Results: Out of 797 patients with hip fractures there were 24 occult hip fractures, the diagnosis was initially missed in 9 of them. In the correctly identified occult fracture patients 8/15 were independently mobile and 9/15 were living in own home compared to 0/9 independently mobile and 2/9 living in own home with missed occult fracture (both p< 0.001, Fisher exact test).7/9 patients with a missed diagnosis had mental confusion but none in the rest (p< 0.001). All patients presented within 10 days from the index visit (range 3–10). There was no obvious history of a fall in 2 patients. 4 patients had restricted straight leg raise ability on initial examination but were dismissed. 8/9 had intra-capsular fracture of which 6 had displaced at repeat presentation and required hemiarthroplasty. Maximum follow-up is 18 months (range 13–18 months) and 1 year mortality rate is 33%.

Discussion: Patients with a missed diagnosis of occult hip fracture appear physiologically less robust compared to the patients who are correctly suspected and investigated for occult fracture. The patients with missed diagnosis have higher ASA grade and their mental confusion, restricted mobility and dependence for activities of daily living are statistically significantly different compared to patients where the diagnosis is correctly suspected. Most of them have sub-capital femoral neck fractures and will most likely return with a displaced fracture within a week. We suggest a low threshold for investigation for occult hip fracture in the elderly, infirm and mentally confused.

There is an ever-increasing clinical need for the regeneration and replacement of tissue to replace soft tissue lost due to trauma, disease and cosmetic surgery. A potential alternative to the current treatment modalities is the use of tissue engineering applications using mesenchymal stem cells that have been identified in many tissue including the infrapatellar fat pad. In this study, stem cells isolated from the infrapatellar fat pad were characterised to ascertain their origin, and allowed to undergo adipogenic differentiation to confirm multilineage differentiation potential.

The infrapatellar fat pad was obtained from total knee replacement for osteoarthritis. Cells were isolated and expanded in monolayer culture. Cells at passage 2 stained strongly for CD13, CD29, CD44, CD90 and CD105 (mesenchymal stem cell markers). The cells stained poorly for LNGFR and STRO1 (markers for freshly isolated bone marrow derived stem cells), and sparsely for 3G5 (pericyte marker). Staining for CD34 (haematopoetic marker) and CD56 (neural and myogenic lineage marker) was negative.

For adipogenic differentiation, cells were cultured in adipogenic inducing medium consisting of basic medium with 10ug/ml insulin, 1uM dexamthasone, 100uM indomethacin and 500uM 3-isobutyl-1-methyl xanthine. By day 16, many cells had lipid vacuoles occupying most of the cytoplasm. On gene expression analyses, the cells cultured under adipogenic conditions had almost a 1,000 fold increase in expression of peroxisome proliferator-activated receptor gamma-2 (PPAR gamma-2) and 1,000,000 fold increase in expression of lipoprotein lipase (LPL). Oil red O staining confirmed the adipogenic nature of the observed vacuoles and showed failure of staining in control cells.

Our results show that the human infrapatellar fat pad is a viable potential autogeneic source for mesenchymal stem cells capable of adipogenic differentiation as well as previously documented ostegenic and chondrogenic differentiation. This cell source has potential use in tissue engineering applications.

Introduction: Articular cartilage is frequently damaged but only shows a limited capacity for repair. Autologous chondrocytes are being used for the repair of focal articular cartilage defects in the ankle but their use has limitations. The use of undifferentiated progenitor cells from other sources is limited by the fact that these cells loose there stem cell characterisation with passage in culture. The fat pad derived stem cells are a possible alternative that maintain multipotentiality at higher passages. We explore the hypothesis that their cell surface characterisation will resemble that of mesenchymal stem cells and will not alter with passage.

Materials and Methods: Cells were isolated from the human fat pad and expanded in monolayer culture. On confluence, they were harvested by digestion and replated at a ratio of 1:3. Cells from passage 2, 4, 6, 8 and 10 were stained and analysed using flow cytometry for a panel of stem cell surface antibodies.

Results: Fat pad derived cells stained strongly for CD13, 29, 44 and 90 (markers of mesenchymal stem cells). The cells stained poorly for 3G5 (pericyte marker), CD34 and CD56 (marker for haematopoetic lineage), and LNG FR and STRO 1 (markers of bone marrow stem cells). These results suggest that the fat pad cell population has surface expression characteristics of mesenchymal stem cells, but differ from bone marrow derived stem cells. It is also important to note that the expression of these cell-surface markers was maintained up to passage 10.

Conclusion: The consistent pattern of cell surface expression, with little change with passage, shows that the proliferation and expansion of the fat pad stem cell population does not lead to major changes in phenotype of these cells. This can potentially allow a significant increase in number sufficient for clinical applications without loosing their multipotentiality.

Resurfacing total hip replacement using metal on metal bearings is increasing in popularity, but the outcomes are currently unclear. We report a series of 23 hips in 20 patients who underwent resurfacing total hip replacement over a period of 4 years. The mean age at surgery was 47 years (21–61). There were 8 females and 12 male patients. The mean follow up was 27 months (range 6 to 50 months). Before performing this study, our impression was that most outcomes were good but that there appeared to be more variability in pain relief than anticipated after conventional total hip replacement. Most were performed for primary osteoarthritis; other diagnoses included AVN, DDH and multiple epiphyseal dysplasia. Outcomes were measured examining x rays, survival of the implant and the Oxford hip questionnaire.

There were no early revisions, but we are aware of one loose acetabular cup (in a patient with DDH) which is asymptomatic but which will probably require revision. There were no femoral neck fractures. The median score using the Oxford hip questionnaire was 15 (mean 23.5; range 12 to 41). These outcomes compare favourably with those reported at 6 months follow up after conventional total hip replacement by the Oxford group (OHQ median score 22; mean 24.3 (12 to 51)).

We conclude that resurfacing metal on metal hip replacement gives comparable results to total hip replacement at early follow up. The age of the Oxford groups patients was considerably older than ours (75 years), and a comparative trial of resurfacing versus conventional hip replacements will be required to determine which gives better short and long term results in young patients. There may be more variability in pain relief after resurfacing THR than after conventional THR, but this will require a larger study to determine with confidence.

The best follow up strategy after hip replacement (THR) is unclear. There are conflicting demands to obtain early diagnosis of loosening, and to minimise clinic visits. It would be desirable to achieve follow up with a validated symptom questionnaire alone, but it is unclear how frequently THRs are asymptomatic during early loosening.

This study examined the relationship between patient reported symptoms after THR using two measures (Oxford Hip Questionnaire (OHQ) and Visual Analogue Scale (VAS)), and the classification of the patients AP x ray of the hip as having definite loosening, possible loosening, or a sound implant. We examined data from 325 patients who had undergone a standard Charnley THR for osteoarthritis. Patients had a mean follow-up of 85 months (range 24–144). X rays were examined by a single Consultant Orthopaedic surgeon, and classified as satisfactory, possible loosening or definite loosening.

As expected, the large majority of patients had a satisfactory appearance on x-ray at all-time points. 12 patients were classified as having definite loosening on the basis of the available x-rays. 8 of these were subsequently listed for revision surgery at review. 20 patients were noted to have evidence of possible loosening. Examination of the Oxford hip questionnaire and VAS data demonstrated a strong relationship between OHQ value and the VAS result for pain (r = 0.78, p < 0.001, Spearman rank correlation). Data were analysed separately (using ROC curves) to determine whether the OHQ or VAS was a satisfactory method of selecting patients who fell into “definite loosening” or “definite or possible loosening” groups. Neither OHQ or VAS were sensitive or specific for definite or possible loosening.

We conclude that x rays are required for early detection of loosening, and that follow up by OHQ or VAS alone is insufficient for this purpose.